We treated MM cells from nine patients (Supplementary Table 1) with ricolinostat at final concentrations of 5 and 10 μM, respectively, and produced a uniform increase in CD38 expression in each case by flow cytometry (Fig. 1g, h). This evidence concerns the gene CD38 and Miyoshi myopathy.